Central Vermont Medical Center reports 8.6% expense growth — or roughly 1%, depending which year it compares against. Porter shows inpatient days down 0.2%; measured against actual 2025, they're up 21%. Rutland Regional asks regulators to s
UVM Health reports operating losses. Its bottom line is positive — $105.2 million in fiscal 2026. Pharmacy revenue beat budget by $129.8 million and operations still lost money; investment income produces the surplus. Its Medical Group lose
In 2025, commercial insurers paid Vermont hospitals 453% of what Medicare would have paid — 503% for outpatient care, and above 5,700% for some chemotherapy drugs. Hospitals want $4.4 billion next year. The Green Mountain Care Board decides
Newly finalized CDC data show Vermont recorded 207 overdose deaths in 2024 — real improvement from the 2022 peak, but still 17 percent above 2020, while 27 comparison jurisdictions dropped 18 percent. Cocaine involvement doubled, xylazine s
Air conditioning is not under attack in Vermont today, but climate policy elsewhere shows how affordable cooling can be squeezed through refrigerant rules, appliance standards, building codes, and approved technologies. As heat risks rise,
Newly released ODNI records show Dr. Anthony Fauci briefed intelligence officials on COVID-19 origins, recommended outside experts for review, and was viewed by some officials as presenting a potential conflict of interest. The documents al
Cholesterol is not poison, and LDL is not automatically a villain. Cholesterol is a vital molecule used for cell membranes, hormones, vitamin D, and digestion. LDL, HDL, and triglycerides are transport and energy markers that only make sens
A 2021 JAMA Cardiology study found that diabetes, metabolic syndrome, hypertension, obesity and smoking carried stronger associations with premature coronary heart disease than LDL cholesterol alone. Dr. Ken Berry’s viral video argues patie
America’s high healthcare costs are not just a domestic failure — they help subsidize cheaper systems abroad. While countries like Switzerland, Norway, and Canada negotiate lower prices, U.S. patients and insurers pay inflated rates for dru
Tianeptine, an unapproved drug with opioid-like effects, is being sold in U.S. retail stores despite federal safety warnings. While some countries have restricted it due to abuse risks, it remains unscheduled federally, creating a regulator
Vermont’s S.193 would create a secure forensic facility aimed at resolving a growing breakdown between the courts, hospitals, and corrections system. The bill shifts the state toward a custody-first model with clinical oversight, raising qu
Vermont lawmakers are advancing a sweeping overhaul of primary care financing that would eliminate copays for routine visits and shift to monthly payments for providers. Supporters say it will strengthen care; critics warn it may raise prem
